Acoleman73 | 36 points
Bulgaria lifts restrictions on Ivermectin. No prescription needed, available now in pharmacies.[-] redcirclehome | 2 points
Prescription is needed
[-] authentic77 | 1 points
Most pharmacies will give it to you without one
[-] stereomatch | 1 points
Related:
Whiteboard Doctor
https://youtu.be/sHZYSWFA9Wc
Early Mild To Moderate COVID-19 And Ivermectin: New Study Completed Out Of Bulgaria
Jan 5, 2021
Dr. Petrov, a cardiologist in Bulgaria and renowned researcher in endovascular therapies, recently completed a study looking at the efficacy of Ivermectin for early mild to moderate COVID-19. Here, we review a Trial Site news article that explores this study and its implications. Ivermectin and COVID-19 have been a topic of interest for going on a year here at WhiteBoard Doctor with our first Ivermectin/COVID-19 video being published way back in April. In this video, we are going to peak into the preliminary information we have on Dr. Petrov's study exploring Ivermectin for early mild to moderate disease. This is based on the Trial Site news article (linked below!) as we wait for the formal data to be published!
https://trialsitenews.com/university-of-sofia-kol-reports-positive-results-of-ivermectin-study-targeting-early-onset-mild-to-moderate-covid-19/ University of Sofia KOL Reports Positive Results of Ivermectin Study Targeting Early Onset Mild-to-Moderate COVID-19
Dec 31, 2020
Professor Ivo Petrov recently reported the results from his study in Bulgaria are in, and the results are encouraging. The study, conducted on mild-to-moderate early stage cases, led to clear benefits, including expedited reduction of symptoms and reduction of viral activity to accelerated clearance, reported Dr. Petrov. The well-known key opinion leader from the Balkan Peninsula did emphasize Ivermectin is best used early on.
Investigator Point of View
Petrov was quoted in Novinite: “The results are encouraging. It is important to note that the stud was conducted in patients with mild to moderate symptoms in the relatively early stages of the disease. And in such patients Ivermectin has a beneficial effect in terms of faster reduction of symptoms and reduction of activity of the virus, faster clearance of the virus from biological fluids, also much faster, between 4-5 days, in contrast from the penetration of the virus.”
Complementary to Vaccines
Just five days ago, TrialSite reported that the Bulgarian physician and professor of cardiology at the University of Sofia shared with the same Bulgarian agency that vaccines are critical for saving lives. He also noted that drugs such as remdesivir and ivermectin were important as well and in fact were complementary to vaccines.
In fact, the U.S. government would agree as they just injected $486 million into a global pharmaceutical company to finance large Phase 3 clinical trials for an experimental monoclonal antibody product. The company is on record that in some cases some people won’t be able to take the vaccine (e.g. allergic reactions, etc.), and in other cases, high risk people may need additional protection.
Can the Drug Serve as Pre-Exposure Prophylaxis (PrEP?)
According to Professor Petrov, Ivermectin actually serves to protect the human cell from the viral entry. He also pointed to mounting evidence that the drug can be preventative—possibly representing an option for PrEP. He pointed to a study of 800 doctors, which revealed that those physicians that actually took the drug had lower incidents of the disease and those that fell ill had less severe symptoms.
Conclusion
TrialSite chronicles different studies and reports around the world. Ivermectin is still not accepted as a potential treatment by most national health authorities, however there is a growing recognition that this could go a long way to help treat large numbers of people, especially in low-to middle-income countries (LMICs)–should there be sufficient evidence for low cost, economical treatments to augment and compliment vaccines. For example, the ANTICOV trial in Sub-Saharan African focuses on potential off-label drugs with the expectation that some poorer nations in Africa may not be able to easily access vaccines.
Moreover, as mentioned earlier, some companies have received large sums of money from the U.S. government to develop monoclonal antibodies, for example, to augment and support a well-balanced, diversified approach to targeting COVID-19.
https://www.reddit.com/r/ivermectin/comments/lfde4b Bulgarian Randomized, Double-Blind, Placebo-Controlled Ivermectin Study Shows Positive Results Against COVID-19:
https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002091-12/BG
https://www.reddit.com/r/ivermectin/comments/lfde4b/_/gml3l33
A European Union-based double-blind study, placebo-controlled Phase 2 clinical trial involving ivermectin in 100 patients with mild COVID-19 recently produced results for the world. Based in the Eastern European nation of Bulgaria, the clinical trial was organized after scientists here learned of the data revealing that the drug blocks penetration of SARS-CoV-2’s transport protein into the cell nucleus and thus inhibits or hinders replication, which could possibly be of use in combating this pandemic.
https://twitter.com/DrAndrewHill/status/1354744844380463105?s=19
https://t.co/6j4f6rrsZ9
Randomised, double-blind, placebo controlled trial of ivermectin in Bulgaria (n=100) shows significantly faster viral clearance, improvements in inflammatory markers and clinical recovery.
https://d7llklyq4a3udg7ze4qzwvplqq-adwhj77lcyoafdy-www-economic-bg.translate.goog/bg/a/view/finalni-testove-za-izpolzvane-na-ivermektin-v-bylgarija Final tests for the use of ivermectin in Bulgaria 26.01.2021
[-] eljuggy | 4 points | Feb 19 2021 16:03:19
Note that the drug is sold for 150 levs (about 100 euros, this is not cheap compared to vetenary product !!!) and that it is produced by a local manufacturer after conducting this trial with positive result (400ug/kg for 3 days):
https://trialsitenews.com/bulgarian-randomized-double-blind-placebo-controlled-ivermectin-study-shows-positive-results-against-covid-19/
permalink
[-] akaariai | 5 points | Feb 19 2021 16:55:24
That local manufacturer is trying to patent their product. Here's hoping they fail miserably in that patent attempt.
permalink
[-] DrTxn | 1 points | Feb 20 2021 06:21:54
It is too bad you can’t get a patent for a new use at a small fee. It would be widely available.
permalink
[-] -tiny-- | 1 points | Feb 26 2021 08:28:15
Are you from Bulgaria?
permalink
[-] [deleted] | 1 points | Feb 19 2021 20:50:02
[deleted]
permalink
[-] authentic77 | 1 points | Feb 21 2021 10:42:19
That's not true. 30 tablets (3mg) cost \~30 eur
permalink
[-] -tiny-- | 1 points | Feb 26 2021 08:26:24
Hi are you from Bulgaria?
permalink
[-] -tiny-- | 1 points | Feb 26 2021 08:26:57
Are you from Bulgaria?
permalink
[-] eljuggy | 1 points | Feb 26 2021 22:35:37
Hi, no sorry just translated comments on bulgarian newspapers sites...
permalink